Pharmacology, Toxicology and Pharmaceutical Science
Infection
68%
Candida Auris
53%
SARS Coronavirus
46%
Antibiotic Resistance
44%
Diseases
42%
Acinetobacter Baumannii
35%
Virus Infection
29%
Antiinfective Agent
26%
Hepatitis C
26%
Respiratory Syncytial Virus Infection
26%
Salmonella
26%
Carbapenem
26%
Seroprevalence
24%
Ciprofloxacin
22%
Human respiratory syncytial virus
22%
Prevalence
21%
Hospital Infection
19%
Coronavirinae
19%
Silver Nanoparticle
19%
Quinolone
18%
Diarrhea
16%
Respiratory Tract Infection
16%
Caspofungin
16%
Nanomaterial
16%
Antifungal Agent
15%
Molecular Epidemiology
15%
Extended Spectrum Beta Lactamase
14%
Gram Negative Infection
14%
Streptococcus pneumonia
14%
Kaposi Sarcoma
14%
Mixed Infection
13%
Multidrug Resistance
13%
Enteroaggregative Escherichia Coli
13%
Klebsiella
13%
Daclatasvir
13%
Sofosbuvir
13%
Angiotensin Converting Enzyme 2
13%
Cell Adhesion Proteins
13%
Human Herpesvirus 8
13%
Hepatitis B
13%
Legionella
13%
Cytomegalovirus
13%
Neisseria gonorrhoeae
13%
Chlamydia Trachomatis
13%
Gonorrhea
13%
Hepatitis E Virus
13%
Hepatitis B Virus
13%
Toxoplasmosis
13%
Thermophile
13%
Human Rotavirus
13%
Macrolide
13%
Helicobacter pylori
13%
Salicylate Sodium
13%
Helicobacter Infection
13%
Intestine Flora
13%
Blastocystosis
13%
Mesoporous Silica
13%
Breast Cancer
13%
Severe Acute Respiratory Syndrome
13%
Receptor
13%
CD82 Antigen
13%
Chemokine
13%
Chryseobacterium
13%
Litsea
13%
Enterococcus avium
13%
Rotavirus
13%
Vasculotropin
13%
Gram Positive Bacterium
13%
Non-Fermenting Gram-Negative Bacterium
13%
Fomes fomentarius
13%
Human Alphaherpesvirus 1
13%
Herpes Simplex Virus 2
13%
Streptococcal Pharyngitis
13%
Viremia
13%
Antibiotics
11%
Methicillin-Resistant Staphylococcus Aureus
11%
Urinary Tract Infection
10%
Immunoglobulin M
9%
Penicillin
9%
Middle East Respiratory Syndrome Coronavirus
8%
Escherichia coli
8%
Immunoglobulin M Antibody
8%
Infectious Agent
8%
Penicillinase
7%
Imipenem
7%
Meropenem
7%
Gastritis
7%
Cholera
6%
Vibrio Cholerae
6%
Varicella Zoster Virus
6%
Cholera Toxin
6%
Tumor Virus
6%
Antioxidant
6%
Lentivirus Vector
6%
Virus Spike Protein
6%
Middle East Respiratory Syndrome
6%
Wound
6%
Acute Gastroenteritis
6%
Neutralizing Antibody
6%
Titanium Dioxide
6%
Immunology and Microbiology
Infection
100%
Prevalence
66%
Candida Auris
46%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Biofilm
28%
Legionella
26%
Middle East Respiratory Syndrome Coronavirus
26%
Scanning Electron Microscopy
23%
Minimum Inhibitory Concentration
21%
Serotype
20%
Human Herpesvirus 8
19%
Salmonella
19%
Seroprevalence
19%
UV-Visible Spectroscopy
19%
Drug Resistance
19%
Seropositivity
19%
Gene Sequence
19%
Klebsiella
19%
Single Nucleotide Polymorphism
18%
RNA Gene
18%
Multidrug Resistance
17%
Gastroenteritis
17%
Hepatitis C
16%
Viral Disease
16%
Haplotype
14%
Morphogenesis
14%
Klebsiella pneumoniae
14%
Real Time Polymerase Chain Reaction
14%
Matrix-Assisted Laser Desorption-Ionization
14%
Antibiotic Resistance
14%
Neutralizing Antibody
14%
Enterobacterales
13%
Sickle Cell
13%
Cytomegalovirus
13%
Dipeptidyl Peptidase IV
13%
X Ray Diffraction
13%
Chlamydia Trachomatis
13%
Neisseria gonorrhoeae
13%
Hepatitis B Virus
13%
Alternative RNA Splicing
13%
Hepatitis B
13%
Human Rotavirus
13%
Protein A
13%
Molecular Typing
13%
Enterococcus avium
13%
Rotavirus
13%
Viremia
13%
Laboratory Test
13%
Next Generation Sequencing
13%
Carbapenem Resistant Enterobacteriaceae
13%
Herpes Simplex Virus 2
13%
Human Alphaherpesvirus 1
13%
Protein Subunit
13%
Clostridium perfringens
13%
Treponema pallidum
13%
Pharyngitis
13%
Thermophile
13%
Capsid
13%
Human respiratory syncytial virus
13%
Cytotoxic T Cell
13%
Time-of-Flight Mass Spectrometry
12%
Susceptibility
12%
Staphylococcus aureus
11%
Herpesviridae
11%
Antimicrobial Agent
11%
Antifungal Activity
10%
Emerging Pathogen
9%
Herpes Simplex Virus
9%
Immunoassay
9%
Antifungal Susceptibility
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Pseudomonas aeruginosa
9%
Virus
9%
Severe Acute Respiratory Syndrome
9%
Firmicutes
8%
Infectious Agent
8%
Ribosomal RNA
8%
Polymerase Chain Reaction
8%
Reverse Transcription Polymerase Chain Reaction
8%
Consensus Sequence
8%
Candida
8%
Cladistics
8%
Acinetobacter Baumannii
8%
Mortality Rate
8%
Peptides
7%
Ribonucleic Acid
7%
Virus Spike
7%
Antibiotic Sensitivity
7%
Immunoglobulin M Antibody
7%
Escherichia coli
7%
Leishmania tropica
6%
Glucose Level
6%
Hepatitis C Virus
6%
Vasculotropin A
6%
Allograft
6%
Cell Adhesion Proteins
6%
Plasmid
6%
In Vitro
6%
Transmission Electron Microscopy
6%
Fourier Transform Infrared Spectroscopy
6%
Medicine and Dentistry
COVID-19
43%
Severe Acute Respiratory Syndrome Coronavirus 2
29%
Cooperation
26%
Infection
21%
Polymerase Chain Reaction
20%
Seroprevalence
20%
Carbapenem
19%
Kidney Graft
19%
Drug Resistance
19%
Kaposi Sarcoma
17%
Pregnant Woman
16%
Retrospective Study
16%
Severe Acute Respiratory Syndrome
16%
Acinetobacter Baumannii
15%
Intensive Care Unit
15%
Antibiogram
14%
Molecular Epidemiology
14%
Sensitivity and Specificity
13%
Endodontic Microleakage
13%
Intensive Care
13%
Salmonella
13%
Quinolone
13%
Chlamydia Trachomatis
13%
Wart Virus
13%
Legionella
13%
Human Herpesvirus 8
13%
Antibody Dependent Enhancement
13%
Streptococcus pneumonia
13%
Alternative RNA Splicing
13%
CD82 Antigen
13%
Nanomaterial
13%
Human Rotavirus
13%
Vibrio Cholerae
13%
Cholera
13%
Cholera Toxin
13%
Nephrotic Syndrome
13%
Chryseobacterium
13%
Glucose Transporter 4
13%
Glucose Uptake
13%
Multidrug Resistance
13%
Rotavirus
13%
Papanicolaou Stain
13%
Streptococcal Pharyngitis
13%
Klebsiella
13%
Syphilis
13%
Antibiotic Resistance
13%
Infection Control
11%
Neonate
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Multilocus Sequence Typing
9%
Scanning Electron Microscopy
8%
Herpesviridae
8%
Immunofluorescence Test
8%
Levofloxacin
8%
Pediatrics
8%
Pseudomonas aeruginosa
8%
Reverse Transcription Polymerase Chain Reaction
8%
Gram-Negative Bacteria
8%
Stenotrophomonas maltophilia
8%
Hospital Infection
8%
Titanium Dioxide Nanoparticle
7%
Blood Culture
7%
Tertiary Care
7%
Emergency Department
7%
Beta Lactam
7%
Real Time Polymerase Chain Reaction
7%
Quinolone Derivative
7%
Antibiotics
6%
Leishmania major
6%
Leishmania tropica
6%
Internal Transcribed Spacer
6%
Cutaneous Leishmaniasis
6%
Cell Adhesion Proteins
6%
Bacterium Adherence
6%
Parvovirus B19
6%
Sickle-Cell Disease
6%
Fifth Disease
6%
Varicella Zoster Virus
6%
Vasculotropin A
6%
Kidney Allograft
6%
Diagnostic Test
6%
Urinary Tract Infection
6%
Acute Gastroenteritis
6%
Chemokine
6%
Next Generation Sequencing
6%
Cytomegalovirus
6%
Recommended Drug Dose
6%
Treatment Exposure
6%
Antidiabetic Activity
6%
Adenoviridae
6%
Viral Gastroenteritis
6%
Lower Respiratory Tract Infection
6%
Human Bocavirus
6%
Viremia
6%
Vaccine Development
6%
Antifungal Susceptibility
6%
Plasmid
6%
Serotype
6%
Community-Acquired Pneumonia
6%
Cystic Fibrosis
6%